Skip to main content
. 2017 Nov 12;2017:7909407. doi: 10.1155/2017/7909407

Figure 2.

Figure 2

CD25 does not contribute to better distinguishing ACS patients from others. (a) CD4+CD25+ and CD4+CD25+Foxp3+ T cells were gated by flow cytometry. (b) Representative images of the proportion of Helios+ cells in CD4+CD25+Foxp3+T cells from a single patient in each group. (c) The percentage of CD4+CD25+ T cells among lymphocytes for each group. (d) The percentage of CD4+CD25+Foxp3+ T cells among CD4+CD25+ T cells for each group. (e) The percentage of CD4+CD25+Foxp3+Helios+ T cells among CD4+CD25+Foxp3+ T cells for each group. (f) The estimated absolute number of CD4+CD25+ T cells for each group. (g) The estimated absolute number of CD4+CD25+Foxp3+ T cells for each group. (h) The estimated absolute number of CD4+CD25+Foxp3+Helios+ T cells for each group.